Bumble Stock Soars After Q4 Earnings Beat and Launch of AI Matchmaker “Dates”
Bumble crushed Wall Street expectations for Q4 2025 with stronger profits, launched a smart new AI dating assistant called Dates, and got an upgrade from JPMorgan.
Feed↓
/ What's going on?
Filter:
Oppenheimer Initiates ProQR Coverage with Outperform and $9 Target – Unmet Need in Liver Diseases Drives Optimism
Oppenheimer starts ProQR Therapeutics (PRQR) coverage with Outperform rating and $9 price target, citing RNA editing potential in liver diseases ahead of 2026 data.
Dollar General Beats Holiday Earnings but Forecasts Slower Same-Store Sales Growth in 2026
Discount giant Dollar General smashed Q4 estimates with huge profit gains but guided for slower 2026 same-store sales growth than many analysts expected, sending shares down 6% premarket amid shopper caution and tough competition.
AstraZeneca Leads Bid for Abivax as Eli Lilly Waits in the Wings
AstraZeneca gains exclusive data access to acquire surging French biotech Abivax (up 1,600% in 2025) before March 23 deadline; Eli Lilly waits in wings amid IBD drug promise.
UiPath Turns GAAP Profitable for First Time Ever — Stock Drops Anyway on Weak FY2027 Guidance
UiPath (PATH) crushed Q4 expectations with 14% revenue growth and record profit, yet shares fell 6.5% after softer FY2027 guidance. CEO explains why AI won’t kill automation software.
Firefly Aerospace Soars: Alpha Flight 7 "Stairway to Seven" Nails Perfect Launch
Firefly Aerospace's Alpha rocket nailed its Stairway to Seven mission on March 11, 2026, reaching orbit, delivering Lockheed payload, and validating Block II upgrades—boosting investor confidence.